20 June 2019
Can-Fite fights hostile takeover
The Israeli drug development company, which has the worst-performing stock on the Tel Aviv Stock Exchange so far this year, has filed a NIS 40 million lawsuit against Capital Point.
17 June 2019
Citi slashes Teva price target
Citi still rates Teva "Buy", but acknowledges that "near-term opioid-related catalysts are unlikely to alleviate investor concerns."
16 June 2019
NSO owner pledges new governance framework
Following repeated criticism of Israeli surveillance company NSO, European private equity firm Novalpina has pledged that it will put a governance framework in place within 90 days.
What sent Fiverr soaring?
Was the Israeli freelancer platform's IPO priced too low, or did the surge represent only a temporary rush of enthusiasm?
13 June 2019
New home purchases fall
The number of new homes sold in Israel in February-April was far below sales in November 2018-January, but 18% more than in February-April 2018.
IAI Elta unveils next generation radar
The operational and combat proven MMR provides air defense capabilities to customers around the world as well as being the radar of Iron Dome, David's Sling and IAI's land-based Barak weapon systems.
UBS: Latest Teva fall unjustified
Both UBS and Oppenheimer say that the additional information required by the judge in Oklahoma opioids case will not affect the $85 million settlement reached by Teva.
Fintech co Sunbit raises $26m
With offices in Los Angeles and Israel, the company transforms the process of financing in-store purchases for consumers across the credit spectrum.